Genomic Characteristics and Phylogenetic Analyses of a Multiple Drug-Resistant Klebsiella pneumoniae Harboring Plasmid-Mediated MCR-1 Isolated from Tai'an City, China
- PMID: 36839493
- PMCID: PMC9963795
- DOI: 10.3390/pathogens12020221
Genomic Characteristics and Phylogenetic Analyses of a Multiple Drug-Resistant Klebsiella pneumoniae Harboring Plasmid-Mediated MCR-1 Isolated from Tai'an City, China
Abstract
Klebsiella pneumoniae is a clinically common opportunistic pathogen that causes pneumonia and upper respiratory tract infection in humans as well as community-and hospital-acquired infections, posing significant threats to public health. Moreover, the insertion of a plasmid carrying the mobile colistin resistance (MCR) genes brings obstacles to the clinical treatment of K. pneumoniae infection. In this study, a strain of colistin-resistant K. pneumoniae (CRKP) was isolated from sputum samples of a patient who was admitted to a tertiary hospital in Tai'an city, China, and tested for drug sensitivity. The results showed that KPTA-2108 was multidrug-resistant (MDR), being resistant to 21 of 26 selected antibiotics, such as cefazolin, amikacin, tigecycline and colistin but sensitive to carbapenems via antibiotic resistance assays. The chromosome and plasmid sequences of the isolated strain KPTA-2108 were obtained using whole-genome sequencing technology and then were analyzed deeply using bioinformatics methods. The whole-genome sequencing analysis showed that the length of KPTA-2108 was 5,306,347 bp and carried four plasmids, pMJ4-1, pMJ4-2, pMJ4-3, and pMJ4-4-MCR. The plasmid pMJ4-4-MCR contained 30,124 bp and was found to be an IncX4 type. It was the smallest plasmid in the KPTA-2108 strain and carried only one resistance gene MCR-1. Successful conjugation tests demonstrated that pMJ4-4-MCR carrying MCR-1 could be horizontally transmitted through conjugation between bacteria. In conclusion, the acquisition and genome-wide characterization of a clinical MDR strain of CRKP may provide a scientific basis for the treatment of K. pneumoniae infection and epidemiological data for the surveillance of CRKP.
Keywords: K. pneumoniae; MCR-1; functional annotation; plasmid; whole-genome sequencing.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Emergence of high-level colistin resistance mediated by multiple determinants, including mcr-1.1, mcr-8.2 and crrB mutations, combined with tigecycline resistance in an ST656 Klebsiella pneumoniae.Front Cell Infect Microbiol. 2023 Jan 26;13:1122532. doi: 10.3389/fcimb.2023.1122532. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 36779188 Free PMC article.
-
Co-transfer of IncFII/IncFIB and IncFII plasmids mediated by IS26 facilitates the transmission of mcr-8.1 and tmexCD1-toprJ1.Ann Clin Microbiol Antimicrob. 2024 Feb 13;23(1):14. doi: 10.1186/s12941-024-00676-5. Ann Clin Microbiol Antimicrob. 2024. PMID: 38350903 Free PMC article.
-
Molecular Mechanisms of Colistin Resistance in Klebsiella pneumoniae in a Tertiary Care Teaching Hospital.Front Cell Infect Microbiol. 2021 Oct 26;11:673503. doi: 10.3389/fcimb.2021.673503. eCollection 2021. Front Cell Infect Microbiol. 2021. PMID: 34765565 Free PMC article.
-
Genomic and phylogenetic analysis of a multidrug-resistant mcr-1-carrying Klebsiella pneumoniae recovered from a urinary tract infection in China.J Glob Antimicrob Resist. 2021 Dec;27:222-224. doi: 10.1016/j.jgar.2021.10.002. Epub 2021 Oct 12. J Glob Antimicrob Resist. 2021. PMID: 34653681
-
Convergence of plasmid-mediated Colistin and Tigecycline resistance in Klebsiella pneumoniae.Front Microbiol. 2024 Jan 3;14:1221428. doi: 10.3389/fmicb.2023.1221428. eCollection 2023. Front Microbiol. 2024. PMID: 38282729 Free PMC article.
References
-
- Liang X., Chen P., Deng B., Sun F.H., Yang Y., Yang Y., He R., Qin M., Wu Y., Yang F., et al. Outcomes and Risk Factors of Bloodstream Infections Caused by Carbapenem-Resistant and Non-Carbapenem-Resistant Klebsiella pneumoniae in China. Infect. Drug Resist. 2022;15:3161–3171. doi: 10.2147/IDR.S367588. - DOI - PMC - PubMed
-
- Livermore D.M., Warner M., Mushtaq S., Doumith M., Zhang J., Woodford N. What remains against carbapenem-resistant En-terobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline. Int. J. Antimicrob. Agents. 2011;7:415–419. doi: 10.1016/j.ijantimicag.2011.01.012. - DOI - PubMed
LinkOut - more resources
Full Text Sources